140 related articles for article (PubMed ID: 36916704)
1. Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic location.
Patel C; Behring M; Al Diffalha S; Dhall D; Lee G; Shanmugam C; Grizzle WE; Manne U
Cancer Med; 2023 Apr; 12(8):9637-9643. PubMed ID: 36916704
[TBL] [Abstract][Full Text] [Related]
2. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location.
Park SY; Lee HS; Choe G; Chung JH; Kim WH
Virchows Arch; 2006 Jul; 449(1):40-7. PubMed ID: 16645863
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
5. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.
Perez RO; Bresciani BH; Bresciani C; Proscurshim I; Kiss D; Gama-Rodrigues J; Pereira DD; Rawet V; Cecconnello I; Habr-Gama A
Int J Colorectal Dis; 2008 Aug; 23(8):757-65. PubMed ID: 18458918
[TBL] [Abstract][Full Text] [Related]
6. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.
Kim DH; Kim JW; Cho JH; Baek SH; Kakar S; Kim GE; Sleisenger MH; Kim YS
Int J Oncol; 2005 Oct; 27(4):957-64. PubMed ID: 16142311
[TBL] [Abstract][Full Text] [Related]
8. [Survival rates of patients with mucinous adenocarcinoma of the colorectum].
Maksimović S
Med Arh; 2007; 61(1):26-9. PubMed ID: 17582971
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
10. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
[TBL] [Abstract][Full Text] [Related]
11. Mucinous differentiation in colorectal cancer--indicator of poor prognosis?
Langner C; Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Vieth M; Rehak P
Histopathology; 2012 Jun; 60(7):1060-72. PubMed ID: 22348346
[TBL] [Abstract][Full Text] [Related]
12. Survival after curative resection for mucinous adenocarcinoma of the colorectum.
Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y
Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888
[TBL] [Abstract][Full Text] [Related]
13. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM
Mod Pathol; 2020 Jul; 33(7):1420-1432. PubMed ID: 32047231
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathological subclassification of mucinous adenocarcinoma of the colorectum.
Li D; Semba S; Wu M; Yokozaki H
Pathol Int; 2005 Dec; 55(12):766-74. PubMed ID: 16287491
[TBL] [Abstract][Full Text] [Related]
15. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.
Lam AK; Ong K; Ho YH
Dis Colon Rectum; 2006 Sep; 49(9):1275-83. PubMed ID: 16912910
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Lymph Node Metastasis and Prognosis in pT1 Colorectal Cancer Patients with Signet-Ring Cell and Mucinous Adenocarcinomas.
Song BR; Xiao CC; Wu ZK
Cell Physiol Biochem; 2017; 41(5):1753-1765. PubMed ID: 28365687
[TBL] [Abstract][Full Text] [Related]
17. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
Debunne H; Ceelen W
Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
[TBL] [Abstract][Full Text] [Related]
18. Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors.
Yoon SO; Kim BH; Lee HS; Kang GH; Kim WH; Kim YA; Kim JE; Chang MS
Mod Pathol; 2009 Aug; 22(8):1102-12. PubMed ID: 19448592
[TBL] [Abstract][Full Text] [Related]
19. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
20. Signet ring cell differentiation in mucinous colorectal carcinoma.
Börger ME; Gosens MJ; Jeuken JW; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
J Pathol; 2007 Jul; 212(3):278-86. PubMed ID: 17471475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
